0001209191-21-045640.txt : 20210706 0001209191-21-045640.hdr.sgml : 20210706 20210706184931 ACCESSION NUMBER: 0001209191-21-045640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210701 FILED AS OF DATE: 20210706 DATE AS OF CHANGE: 20210706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Urso David M CENTRAL INDEX KEY: 0001604256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 211075676 MAIL ADDRESS: STREET 1: C/O MEI PHARMA, INC. STREET 2: 11975 EL CAMINO REAL, SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-01 0 0001262104 MEI Pharma, Inc. MEIP 0001604256 Urso David M C/O MEI PHARMA, INC. 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 0 1 0 0 Chief Operating Officer & GC Common Stock 2021-07-02 4 F 0 24825 2.94 D 49281 D Stock Option (Right to Buy) 2.95 2021-07-01 4 A 0 600000 0.00 A 2031-07-01 Common Stock 600000 600000 D Stock Option (Right to Buy) 1.57 2025-07-28 Common Stock 127500 127500 D Stock Option (Right to Buy) 1.36 2026-07-29 Common Stock 130000 130000 D Stock Option (Right to Buy) 2.83 2027-07-06 Common Stock 130000 130000 D Stock Option (Right to Buy) 4.33 2028-06-22 Common Stock 130000 130000 D Stock Option (Right to Buy) 4.28 2028-07-12 Common Stock 220000 220000 D Stock Option (Right to Buy) 2.52 2029-07-01 Common Stock 350000 350000 D Stock Option (Right to Buy) 3.49 2030-07-02 Common Stock 525000 525000 D Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units. One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022. All of such options are presently exercisable. One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. /s/ Brian G. Drazba, as attorney in fact 2021-07-06